Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-24 8:59 pm Sale | 2025-09-24 | 13D | Monopar Therapeutics Inc. MNPR | Tactic Pharma LLC | 506,199 7.500% | -531,197 (-51.20%) | Filing History |
| 2025-08-14 10:58 am Purchase | 2025-06-30 | 13G | Monopar Therapeutics Inc. MNPR | JANUS HENDERSON GROUP PLC JHG | 1,172,368 19.200% | 37,962 (+3.35%) | Filing History |
| 2025-05-14 11:59 am Purchase | 2025-03-31 | 13G | Monopar Therapeutics Inc. MNPR | JANUS HENDERSON GROUP PLC JHG | 1,134,406 18.600% | 87,507 (+8.36%) | Filing History |
| 2025-02-14 6:25 pm Purchase | 2024-12-31 | 13G | Monopar Therapeutics Inc. MNPR | RA CAPITAL MANAGEMENT L.P. | 620,116 9.900% | 108,909 (+21.30%) | Filing History |
| 2025-02-14 4:00 pm Sale | 2024-12-31 | 13G | Monopar Therapeutics Inc. MNPR | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -200,000 (Position Closed) | Filing History |
| 2025-02-12 09:45 am Purchase | 2024-12-31 | 13G | Monopar Therapeutics Inc. MNPR | Adage Capital Management, L.P. | 599,195 9.860% | 599,195 (New Position) | Filing History |
| 2025-02-07 5:01 pm Purchase | 2024-12-09 | 13D | Monopar Therapeutics Inc. MNPR | Monopar Therapeutics MNPR | 704,829 13.400% | 704,829 (New Position) | Filing History |
| 2025-01-08 11:38 am Purchase | 2024-12-31 | 13G | Monopar Therapeutics Inc. MNPR | JANUS HENDERSON GROUP PLC JHG | 1,046,899 17.200% | 484,417 (+86.12%) | Filing History |
| 2024-12-17 5:01 pm Purchase | 2024-12-09 | 13D | Monopar Therapeutics Inc. MNPR | Tactic Pharma LLC | 1,037,396 19.200% | 1,037,396 (New Position) | Filing History |
| 2024-11-06 3:13 pm Purchase | 2024-10-31 | 13G | Monopar Therapeutics Inc. MNPR | JANUS HENDERSON GROUP PLC JHG | 562,482 10.900% | 562,482 (New Position) | Filing History |
| 2024-10-31 4:17 pm Purchase | 2024-10-24 | 13G | Monopar Therapeutics Inc. MNPR | RA CAPITAL MANAGEMENT L.P. | 511,207 9.700% | 511,207 (New Position) | Filing History |
| 2024-10-28 06:00 am Purchase | 2024-10-23 | 13G | Monopar Therapeutics Inc. MNPR | ASTRAZENECA PLC | 387,329 9.900% | 387,329 (New Position) | Filing History |
| 2024-10-24 4:08 pm Purchase | 2024-10-24 | 13G | Monopar Therapeutics Inc. MNPR | TANG CAPITAL MANAGEMENT, LLC | 200,000 5.100% | 200,000 (New Position) | Filing History |
| 2023-06-02 4:57 pm Purchase | 2023-05-26 | 13G | Monopar Therapeutics Inc. MNPR | Klunzinger Jeffrey R. | 138,560 5.240% | 138,560 (New Position) | Filing History |